Treating Migraine

Affordable access to Migraine treatments can be a challenge. It's common to pay several hundred dollars each month for a few Migraine medications.

Affordable Access to Migraine Treatments

Affordable access to Migraine treatments can be a challenge. It's common to pay several hundred dollars each month for a few Migraine medications.Read More →

Prevent that Next Migraine Attack by Blocking Blue Light

Blue light from electronic screens may trigger Migraine attacks. Check out these useful strategies for preventing that next Migraine.Read More →

Chronic Migraine Care Compromised by Barriers

Fewer than 5% of persons with Chronic Migraine overcame the barriers to appropriate and adequate Migraine care, indicating huge unmet need.Read More →

Emgality™ Approved for Migraine Prevention in Adults

It's good news for Migraine patients as Eli Lilly and Company's Emgality™ (galcanezumab-gnlm) became the third new CGRP monoclonal antibody approved by the FDA for Migraine Prevention in Adults. With Emgality™ approved for Migraine prevention, patients have choices of preventive treatments were developed specifically for Migraine.Read More →

Improving Migraine with Healthy Sleep Hygiene

Did you know that nearly half of all Mgraine attacks occur in the early morning hours? The importance of healthy sleep hygiene can't be overstated.Read More →

Side-by-Side Comparison of Aimovig, Ajovy, and Emgality

Comparing CGRP Blockers for Migraine Prevention

Comparing CGRP blockers is the next big challenge for Migraine patients. Now that we have three new preventive options specifically designed for Migraine, we’re faced with that all-important question: Which one should we choose: Aimovig, Ajovy, or Emgality?Read More →